ATAI vs EIX · rev $308.0K vs P/E 7.3, rev $17.60B
ATAI Life Sciences BV (ATAI) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ATAI revenue for 2024-12-31 was $308.0K. Net income was -$150.0M. Revenue was down 1.9% from 2023-12-31 to 2024-12-31. ATAI currently screens at market cap $555.8M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ATAI currently screens at market cap $555.8M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ATAI and EIX stock pages for the full models.
Not investment advice.